INLB
Item 9 Labs Corp.
OTC Markets OTCPKUSDEQUITY
DELAYED
Last price
0.00
■ 0.00 (0.00%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
—
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
20.00K
Market cap
—
P/E (TTM)
—
52W range
0.00 – 0.00
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
0.00%
-3.7%
3M
0.00%
-3.1%
6M
0.00%
-11.1%
YTD
0.00%
-12.3%
1Y
0.00%
-20.0%
3Y
-99.23%
-173.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Total revenue | $21.76M | $21.94M | -0.8% |
| Operating revenue | $21.76M | $21.94M | -0.8% |
| Cost of revenue | $14.45M | $13.32M | +8.4% |
| Gross profit | $7.31M | $8.61M | -15.1% |
| Selling, general & admin | $18.83M | $12.89M | +46.1% |
| Total operating expense | $20.43M | $14.21M | +43.7% |
| Operating income | -$13.12M | -$5.60M | -134.2% |
| Net interest income | -$6.41M | -$5.30M | -21.1% |
| Pre-tax income | -$31.17M | -$10.91M | -185.8% |
| Tax provision | $13.22K | $0 | — |
| Net income | -$31.14M | -$10.91M | -185.6% |
| Net income to common | -$31.14M | -$10.91M | -185.6% |
| Basic EPS | -0.33 | -0.14 | -135.7% |
| Diluted EPS | -0.33 | -0.14 | -135.7% |
| EBIT | -$24.75M | -$5.61M | -341.2% |
| EBITDA | -$22.83M | -$4.35M | -424.8% |
| Basic shares | 95.69M | 78.59M | +21.8% |
| Diluted shares | 95.69M | 78.59M | +21.8% |
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Cash & equivalents | $85.64K | $1.45M | -94.1% |
| Cash & short-term investments | $85.64K | $1.45M | -94.1% |
| Accounts receivable | $586.27K | $1.45M | -59.5% |
| Inventory | $2.46M | $6.39M | -61.4% |
| Total current assets | $3.55M | $10.10M | -64.8% |
| Property, plant & equipment | $21.96M | $11.03M | +99.0% |
| Goodwill & intangibles | $69.97M | $76.72M | -8.8% |
| Total assets | $110.76M | $116.81M | -5.2% |
| Total current liabilities | $40.59M | $14.99M | +170.8% |
| Current debt | $19.67M | $5.81M | +238.4% |
| Long-term debt | $7.22M | $14.96M | -51.8% |
| Total debt | $27.85M | $20.93M | +33.0% |
| Total liabilities | $48.82M | $30.71M | +59.0% |
| Retained earnings | -$65.02M | -$33.87M | -91.9% |
| Shareholder equity | $61.96M | $86.10M | -28.0% |
| Working capital | -$37.03M | -$4.89M | -656.8% |
| Net tangible assets | -$8.01M | $9.38M | -185.5% |
| Shares issued | 109.95M | 107.07M | +2.7% |
| Line item | 2022 | 2021 | YoY |
|---|---|---|---|
| Net income | -$31.18M | -$10.91M | -185.9% |
| Depreciation & amortisation | $1.92M | $1.26M | +52.5% |
| Stock-based compensation | $3.00M | $1.72M | +74.8% |
| Change in working capital | $7.86M | -$2.88M | +373.2% |
| Operating cash flow | -$2.25M | -$5.99M | +62.4% |
| Capital expenditure | -$5.46M | -$2.24M | -143.4% |
| Investing cash flow | -$5.16M | -$3.92M | -31.7% |
| Financing cash flow | $6.05M | $11.28M | -46.4% |
| Free cash flow | -$7.71M | -$8.23M | +6.3% |
| End cash position | $85.64K | $1.45M | -94.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.00
+0.00% from price
SMA 20
0.00
0.00% from price
SMA 50
0.00
0.00% from price
SMA 100
0.00
+0.00% from price
SMA 200
0.00
0.00% from price
EMA 12
0.00
+0.00% from price
EMA 26
0.00
+0.00% from price
EMA 50
0.00
+0.00% from price
RSI (14)
37.9
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
—
Realised vol 30D
0.0%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.00
Trend bias
Below 200
0.00%
Risk profile
Beta vs SPY
0.00
Less volatile than market
Correlation to SPY
—
—
Realised vol 30D
0.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
0.0%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
—
5Y monthly, from filing
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.